Skip to main content
Clinical Trials/NCT06583460
NCT06583460
Recruiting
Not Applicable

Systematic Intervention to Improve Sexual Dysfunction in Adjuvant Breast Cancer Patients

Center Eugene Marquis1 site in 1 country60 target enrollmentDecember 9, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer Female
Sponsor
Center Eugene Marquis
Enrollment
60
Locations
1
Primary Endpoint
Sexual satisfaction
Status
Recruiting
Last Updated
9 months ago

Overview

Brief Summary

The aim of this clinical trial is to compare the benefit of early, systematic, multidisciplinary oncosexological care versus on-demand care on the sexual health of women with breast cancer.

Detailed Description

The aim of the study is to evaluate the effectiveness of early, systematized oncosexology care on perceived sexual health at 18 months, compared with oncosexology care on demand. All included patients are evaluated at Baseline and M18 following initiation of antineoplastic treatments associated with surgery. Patients who accepted additional oncosexological care were also assessed at M4, M8 and M12. The content of support care is detailed in section "arms and interventions". Oncosexology consultations with the sexologist and the medical support care of any organic disorders remain accessible to all patients, on request, including the group of patients who do not wish to participate in early and systematic oncosexology care.

Registry
clinicaltrials.gov
Start Date
December 9, 2024
End Date
June 9, 2028
Last Updated
9 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women ≥ 18 years (menopausal or not),
  • Localized breast cancer with or without lymph node involvement,
  • Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.),
  • Patient affiliated or benefiting from the social security system,
  • Patient informed and informed consent signed.

Exclusion Criteria

  • History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years,
  • Pregnant or breast-feeding women,
  • Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards,
  • Patients unable to comply with the study schedule for social, medical or psychological reasons.

Outcomes

Primary Outcomes

Sexual satisfaction

Time Frame: Measured at baseline and at 18 months following initiation of treatment and surgical.

Sexual satisfaction score measured by self-questionnaire using the EORTC Quality of Life Questionnaire Sexual Health scale (EORTC QLQ-SH22).

Study Sites (1)

Loading locations...

Similar Trials